Literatur
- 1
Alizadeh A A, Eisen M B, Davis R E. et al .
Distinct types
of diffuse large B-cell lymphoma identified by gene expression profiling.
Nature.
2000;
403
503-511
- 2
Armstrong S A, Staunton J E, Silverman L B. et al .
MLL translocations specify
a distinct gene expression profile that distinguishes a unique leukemia.
Nat
Genet.
2002;
30
41-47
- 3
Ashburner M, Ball C A, Blake J A. et al .
Gene ontology: tool for
the unification of biology. The Gene Ontology Consortium.
Nat
Genet.
2000;
25
25-29
- 4
Brazma A, Hingamp P, Quackenbush J. et al .
Minimum information about a microarray
experiment (MIAME)-toward standards for microarray data.
Nat
Genet.
2001;
29
365-371
- 5
Cobleigh M A, Vogel C L, Tripathy D. et al .
Multinational study of the efficacy and
safety of humanized anti-HER2 monoclonal antibody in women who have
HER2-overexpressing metastatic breast cancer that has progressed
after chemotherapy for metastatic disease.
J Clin Oncol.
1999;
17
2639-2648
- 6
Duggan D J, Bittner M, Chen Y, Meltzer P, Trent J M.
Expression
profiling using cDNA microarrays.
Nat Genet.
1999;
21
(Suppl 1)
10-14
- 7
Dysvik B, Jonassen I.
J-Express: Exploring gene
expression data using Java.
Bioinformatics.
2001;
17
369-370
- 8
Eisen M B, Spellman P T, Brown P O, Botstein D.
Cluster
analysis and display of genome-wide expression patterns.
Proc
Natl Acad Sci USA.
1998;
95
14 863-14 868
- 9
Enard W, Khaitovich P, Klose J. et al .
Intra- and interspecific variation in primate
gene expression patterns.
Science.
2002;
296
340-343
- 10
Fenaux P, Le D eley MC, Castaigne S. et al. European APL 91 Group .
Effect
of all transretinoic acid in newly diagnosed acute promyelocytic leukemia.
Results of a multicenter randomized trial.
Blood.
1993;
82
3241-3249
- 11
Golub T R, Slonim D K, Tamayo P. et al .
Molecular classification of cancer: class
discovery and class prediction by gene expression monitoring.
Science.
1999;
286
531-537
- 12
Haferlach T, Schoch C.
WHO-Klassifikation der
akuten myeloischen Leukämien (AML) und der myelodysplastischen
Syndrome (MDS).
Dtsch Med Wochenschr.
2002;
127
447-450
- 13
Kantarjian H, Sawyers C, Hochhaus A. et al .
Hematologic and cytogenetic responses to
imatinib mesylate in chronic myelogenous leukemia.
N Engl
J Med.
2002;
346
645-652
- 14
Kohlmann A, Dugas M, Schoch C. et al .
Gene expression profiles of distinct AML
subtypes in comparison to normal bone marrow.
Blood.
2001;
98
91a
- 15 Kohlmann A, Dugas M, Schoch C. et al .Gene expression profiles of distinct cytogenetic
AML subtypes as defined by the new WHO classification: A study of
45 patients. Oncogenomics Conference 2002. http://www.nhgri.nih.gov/ CONF/Oncogenomics2002/abstracts.cgi?view
= 300
- 16
Lockhart D J, Dong H, Byrne M C. et al .
Expression monitoring by hybridization
to high-density oligonucleotide arrays.
Nat Biotechnol.
1996;
14
1675-1680
- 17
Ohyama H, Zhang X, Kohno Y. et
al .
Laser capture microdissection-generated target
sample for high-density oligonucleotide array hybridization.
Biotechniques.
2000;
29
530-536
- 18
Phimister B.
Oncogenomics:
cancer and technology.
Nat Genet.
2002;
31
117-119
- 19
Pomeroy S L, Tamayo P, Gaasenbeek M. et al .
Prediction of central nervous system embryonal
tumour outcome based on gene expression.
Nature.
2002;
415
436-442
- 20
Ramaswamy S, Tamayo P, Rifkin R. et al .
Multiclass cancer diagnosis using tumor
gene expression signatures.
Proc Natl Acad Sci USA.
2001;
98
15 149-15 154
- 21
Ramaswamy S, Golub T R.
DNA microarrays
in clinical oncology.
J Clin Oncol.
2002;
20
1932-1941
- 22
Schoch C, Kohlmann A, Schnittger S. et al .
Acute myeloid leukemias with reciprocal
rearrangements can be distinguished by specific gene expression
profiles.
Proc Natl Acad Sci USA.
2002;
99
10 008-10 013
- 23
Southern E, Mir K, Shchepinov M.
Molecular
interactions on microarrays.
Nat Genet.
1999;
21
(Suppl 1)
5-9
- 24
Tusher V G, Tibshirani R, Chu G.
Significance
analysis of microarrays applied to the ionizing radiation response.
Proc
Natl Acad Sci USA.
2001;
98
5116-5121
- 25
Virtaneva K, Wright F A, Tanner S M. et al .
Expression profiling reveals fundamental
biological differences in acute myeloid leukemia with isolated trisomy
8 and normal cytogenetics.
Proc Natl Acad Sci USA.
2001;
98
1124-1129
- 26 World Health Organization .Classification
of Tumours: Pathology & Genetics. IARC Press,
Lyon Tumours of Haematopoietic and Lymphoid Tissues.
Ed. Jaffe ES, Harris NL, Stein H, Vardiman JW 2001
- 27
Yeoh E J, Ross M E, Shurtleff S A. et al .
Classification, subtype
discovery, and prediction of outcome in pediatric acute lymphoblastic
leukemia by gene expression profiling.
Cancer Cell.
2002;
1
133-143
- 28
Zhan F, Hardin J, Kordsmeier B. et al .
Global gene expression profiling of multiple
myeloma, monoclonal gammopathy of undetermined significance, and
normal bone marrow plasma cells.
Blood.
2002;
99
1745-1757
1 Die Arbeiten wurden
unterstützt von der Deutschen José Carreras Leukämie-Stiftung
e.V. (DJCLS-R00/13).
Priv.-Doz. Dr. med. Dr. phil. Torsten Haferlach
Labor für Leukämiediagnostik,
Medizinische Klinik III, Klinikum Großhadern, Ludwig-Maximilians-Universität
Marchioninistraße 15
81377 München
eMail: torsten.haferlach@med3.med.uni-muenchen.de